相关实验视频

Updated: Jan 11, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

在早期骨质发生过程中由冷化PRP诱导的介质干细胞分化

Marcel Rodrigues Ferreira¹, Geórgia da Silva Feltran¹, Anderson Moreira Gomes¹

¹Lab. of Bioassays and Cellular Dynamics, Department of Chemistry and Biochemistry, Institute of Biosciences, UNESP: São Paulo State University, Botucatu, São Paulo, Brazil.

Cell biology international

|November 13, 2025

概括

富于血小板的血 (PRP) 促进介质干细胞 (MSC) 的增殖和粘附,但与骨质诱导介质相比,其骨质生成承诺较弱. 需要进一步的研究来优化PRP用于骨愈合应用.

科学领域:

生物材料科学生物材料科学
干细胞生物学干细胞生物学
再生医学是一种再生医学.

背景情况:

富含血小板血 (PRP) 含有大量影响组织修复的生物活性因素.
在人类介质干细胞 (hMSCs) 中,PRP对骨质母细胞承诺的具体影响尚未完全理解.

研究的目的:

研究hMSCs对PRP和冷化PRP (lyPRP) 的转录反应.
为了比较PRP/lyPRP与骨质诱导介质 (OM) 的骨质诱导潜力.

主要方法:

在24小时或7天内,hMSC暴露于PRP,lyPRP或OM.
一个由48个基因组成的小组评估了分化,粘附,细胞周期和信号通路的量化.
分析使用了双向ANOVA,主要组件分析 (PCA) 和相关性网络.

主要成果:

PRP和lyPRP上调了与增殖,活力和粘附相关的基因 (例如,环林/CDK,SRC轴).
与OM相比,PRP/lyPRP对法定骨质生殖标志物 (RUNX2,SP7,ALPL) 的诱导作用较小.
经过PCA和网络分析,随着时间的推移,PRP/lyPRP和OM治疗之间发现了不同的信号模式.

结论:

在hMSC中,PRP和lyPRP促进早期的增殖和矩阵相互作用状态.
与OM相比,PRP/lyPRP表现出较低的骨诱导转录压力.
优化PRP配方,剂量和时间对于增强治疗目标的骨质分化至关重要.

关键词:

基因表达分析基因表达分析介质细胞干细胞介质细胞干细胞骨质母细胞分化分化富于血小板血的血含量是多少治疗应用治疗应用

更多相关视频

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells

Published on: March 22, 2024

Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells

Isolation, Propagation, and Prion Protein Expression During Neuronal Differentiation of Human Dental Pulp Stem Cells

Published on: March 18, 2019

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...